| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/01/2011 | CA2442917C Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2398053C Method for the fractionation of oil and polar lipid-containing native raw materials |
| 01/27/2011 | WO2011011706A2 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |
| 01/27/2011 | WO2011011506A1 Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
| 01/27/2011 | WO2011011302A2 Differentiation of human embryonic stem cells |
| 01/27/2011 | WO2011011300A2 Differentiation of human embryonic stem cells |
| 01/27/2011 | WO2011011123A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| 01/27/2011 | WO2011011092A1 Methods and compositions to reduce oxidative stress |
| 01/27/2011 | WO2011010706A1 Fgf21 cis-element binding substance |
| 01/27/2011 | WO2011010678A1 Polyphenol-containing composition for oral administration or external use and use of same |
| 01/27/2011 | WO2011010583A1 Method for screening for oligonucleotide, and oligonucleotide library |
| 01/27/2011 | WO2011010174A1 Crystalline form i rosuvastatin zinc salt |
| 01/27/2011 | WO2011010013A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway |
| 01/27/2011 | WO2011009845A1 Pyridone glucokinase activators |
| 01/27/2011 | WO2011009360A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings |
| 01/27/2011 | WO2010142956A3 Aroylthiourea and arylthiocarbonylurea derivatives |
| 01/27/2011 | WO2010105048A9 Thiazolidinedione analogues |
| 01/27/2011 | WO2010090876A3 Satiation peptide administration |
| 01/27/2011 | WO2010088518A3 Heterocyclic modulators of gpr119 for treatment of disease |
| 01/27/2011 | WO2010056630A8 Triazolopyrimidinones and methods of use thereof |
| 01/27/2011 | US20110021792 Sulfur-containing proanthocyanidin oligomer composition and production method thereof |
| 01/27/2011 | US20110021766 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 01/27/2011 | US20110021747 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/27/2011 | US20110021634 Processes for preparing metformin hydrochloride |
| 01/27/2011 | US20110021633 Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States |
| 01/27/2011 | US20110021617 Medicinal Acidic Cannabinoids |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021597 3-phenoxymethylpyrrolidine compounds |
| 01/27/2011 | US20110021590 Aminopyrrolidinone derivatives and uses thereof |
| 01/27/2011 | US20110021586 Phenyl-sulfamates as aromatase inhibitors |
| 01/27/2011 | US20110021584 Methods and Assays for Detecting and Treating Hypoglycemia |
| 01/27/2011 | US20110021576 Novel process to prepare pioglitazone via several novel intermediates |
| 01/27/2011 | US20110021570 Pyridone glucokinase activators |
| 01/27/2011 | US20110021564 Method of treating binge eating disorder and obesity resulting from binge eating behavior |
| 01/27/2011 | US20110021561 Quinoline compound and pharmaceutical composition, preparation method and uses thereof |
| 01/27/2011 | US20110021559 Aminopyridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021557 Deuterium-enriched pyridinonecarboxamides and derivatives |
| 01/27/2011 | US20110021551 TREATMENT WITH OPIOID ANTAGONISTS AND mTOR INHIBITORS |
| 01/27/2011 | US20110021532 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/27/2011 | US20110021526 Pharmaceutical Composition for Treatment of Diabetic Complications |
| 01/27/2011 | US20110021525 P70S6 Kinase Modulators and Method of Use |
| 01/27/2011 | US20110021521 Fused heterocyclic compounds as ion channel modulators |
| 01/27/2011 | US20110021519 Tetrahydropteridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021514 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 01/27/2011 | US20110021513 Modulators of interleukin-1 receptor-associated kinase |
| 01/27/2011 | US20110021512 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 |
| 01/27/2011 | US20110021508 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement |
| 01/27/2011 | US20110021507 Inhibiting antipsychotic-induced weight gain |
| 01/27/2011 | US20110021504 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
| 01/27/2011 | US20110021497 Amino triazoles as pi3k inhibitors |
| 01/27/2011 | US20110021491 Compounds, pharmaceutical composition and methods relating thereto |
| 01/27/2011 | US20110021487 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use |
| 01/27/2011 | US20110021480 17-beta HSD1 and STS Inhibitors |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110021423 Rapid Acting Insulin Analogues |
| 01/27/2011 | US20110021422 Method and compositions for prevention and treatment of diabetic and aged skin |
| 01/27/2011 | US20110021421 Liquid enteral nutritional composition with a low specific protein volume |
| 01/27/2011 | US20110021420 Modification of feeding behaviour |
| 01/27/2011 | US20110021419 Methods and Compositions for the Treatment of Heart Failure and Other Disorders |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020471 Erythrocyte atp-release modulators |
| 01/27/2011 | US20110020464 Methods of treatment using thymus-derived compositions |
| 01/27/2011 | US20110020460 Gpr 119 modulators |
| 01/27/2011 | US20110020455 Solid dispersion and pharmaceutical composition of the same, and production processes thereof |
| 01/27/2011 | US20110020443 Slow release magnesium composition and uses thereof |
| 01/27/2011 | US20110020407 Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy |
| 01/27/2011 | US20110020400 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020389 Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 01/27/2011 | US20110020377 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020376 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020372 Follistatin domain containing proteins |
| 01/27/2011 | US20110020354 G-protein coupled receptor ligands and methods |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020347 Anti-brak (cxcl14) human monoclonal antibody and use thereof |
| 01/27/2011 | US20110020345 Drug fusions and conjugates |
| 01/27/2011 | US20110020342 Igf-1 fusion polypeptides and therapeutic uses thereof |
| 01/27/2011 | US20110020338 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes |
| 01/27/2011 | US20110020330 Antibody inhibitors of gdf-8 and uses thereof |
| 01/27/2011 | US20110020328 Antibody formulations |
| 01/27/2011 | US20110020312 Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 01/27/2011 | US20110020309 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergice disease |
| 01/27/2011 | US20110020300 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes |
| 01/27/2011 | US20110020297 Dner-mediated cell purification of pancreatic endocrine pre-progenitor cells and their progeny |
| 01/27/2011 | US20110020296 Methods for treating diseases and increasing longevity |
| 01/27/2011 | US20110020294 Inducement of organogenetic tolerance for pancreatic xenotransplant |
| 01/27/2011 | US20110020285 Composition Containing Cacao and Spirulina |
| 01/27/2011 | US20110020284 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020279 Rabies cure |
| 01/27/2011 | US20110020273 Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof |
| 01/27/2011 | US20110020269 Methods and compositions for modifying t cell immune responses and inflammation |
| 01/27/2011 | US20110020264 Method and Composition for the Treatment of Scars |
| 01/27/2011 | US20110020250 Personal-care composition comprising a hydrocarbon wax and a polar oil |
| 01/27/2011 | US20110020229 Multi-Component Biological Transport Systems |
| 01/27/2011 | US20110020227 Polysaccharide-containing block copolmer particles and uses thereof |
| 01/27/2011 | CA2769474A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway |
| 01/27/2011 | CA2768644A1 Differentiation of human embryonic stem cells |
| 01/27/2011 | CA2768643A1 Differentiation of human embryonic stem cells |
| 01/27/2011 | CA2766522A1 Pyridone glucokinase activators |